CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Novo Nordisk cans two more trials of IL-6 heart drug for futility

ziltivekimab
Related Companies

Read the original article

Published by Endpoints News on September 7, 2026 7:53 AM

Read Original